• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SMITH & NEPHEW, INC. OR3O DUAL MOBILITY LINER 40/52; PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/POLYMER, POROUS UNCEMENTED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SMITH & NEPHEW, INC. OR3O DUAL MOBILITY LINER 40/52; PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/POLYMER, POROUS UNCEMENTED Back to Search Results
Catalog Number 71358203
Medical Device Problem Code Device Dislodged or Dislocated (2923)
Health Effect - Clinical Codes Pain (1994); Joint Dislocation (2374)
Date of Event 05/21/2025
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that, after thr surgery had been performed on (b)(6) 2024, the patient experienced a left dislocation of the or3o dual mobility liner 40/52 after moving to lateral side on bed.This adverse event was solved by a medical intervention on (b)(6) 2025, in which captain morgan technique was performed.Current patient's health status is unknown.
 
Additional Manufacturer Narrative
Internal complaint reference: (b)(4).This complaint was opened by smith+nephew to document a patient complication related to a product problem with a smith+nephew device.The reported issue(s) relate to known inherent device and/or procedural risks that are appropriately documented in our risk files.Smith+nephew will continue to monitor trends in accordance with our post-market surveillance process and take necessary action as required if anticipated severity and/or occurrence rates are exceeded.Smith+nephew has no reason to suspect that the product failed to meet any specifications at the time of manufacture.Based on our review of all currently available information, we are unable to identify a definitive root cause.However, as the use of our product cannot be excluded as a potential cause or contributory factor to the reported issue, we are conservatively submitting this report in accordance with applicable regulations.If additional information becomes available that alters the conclusions of this report, a follow-up report will be submitted as required.
 
Additional Manufacturer Narrative
Given the nature of the alleged incident, the device could not be returned for evaluation.The clinical/medical investigation concluded that, the dislocation event appears to have been influenced by multiple factors, including the patient's history of revision surgery, prior dislocation, and underlying comorbidities.The incident required hospitalization and was managed through closed reduction, with the outcome documented as ¿recovered/resolved.¿ while the event was initially assessed as possibly related to the study device and procedure, subsequent documentation indicated it was unrelated.The current status of the patient is not available.A review of the production order did not reveal a manufacturing abnormality that could have caused or contributed to the reported incident.A review of complaint history of the previous 12 months revealed a similar event for the listed part number, this failure mode will be monitored for future complaints for any necessary corrective actions.A review of the instructions for use documents for total hip systems revealed that dislocation has been identified in warnings and precautions, that may result from improper selection of the neck length and cup, stem positioning, muscle looseness and/or malpositioning of components.A review of the risk management file revealed this failure mode was previously identified.The anticipated risk level is still adequate.A historical review concluded that there are no prior actions related to this product and event.At this time, we have no evidence to conclude that the product failed to meet any specifications at the time of manufacture.Based on this investigation, the need for corrective action is not indicated.Should additional information be received, the complaint will be reopened.No further investigation is warranted for this complaint; however, we will continue to monitor for future complaints and investigate as necessary.We consider this investigation closed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OR3O DUAL MOBILITY LINER 40/52
Common Device Name
PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/POLYMER, POROUS UNCEMENTED
Manufacturer (Section D)
SMITH & NEPHEW, INC.
1450 brooks rd.
memphis TN 38116
Manufacturer (Section G)
SMITH & NEPHEW, INC.
1450 brooks rd.
memphis TN 38116
Manufacturer Contact
holly topping
1450 brooks rd.
memphis, TN 38116
5123913905
MDR Report Key22465349
Report Number1020279-2025-01203
Device Sequence Number11792641
Product Code LPH
UDI-Device Identifier00885556712245
UDI-Public885556712245
Combination Product (Y/N)N
Initial Reporter CountryHK
PMA/510(K) Number
K232667
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2024
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Other,Foreign,Study,Health Professional
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 08/11/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue Number71358203
Device Lot Number24BM05850
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 06/17/2025
Supplement Date Received by Manufacturer08/11/2025
Initial Report FDA Received Date07/09/2025
Supplement Report FDA Received Date08/11/2025
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured02/12/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
OR3O DM XLPE INSERT 28/40:71358217, (B)(6); OXINIUM FEM HD 12/14 28MM +8:71342808,(B)(6).; POLARSTEM STEM STD TI/HA 1 NON-C:75100464,(B)(6); REDAPT MODULAR SHELL 52MM:71352352,(B)(6)
Outcome Attributed to Adverse Event Required Intervention;
Patient Age70 YR
Patient SexFemale
Patient Weight54 KG
-
-